South Wales, Aug. 21 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "RELIZORBNEO" on Aug. 11. The details about the trademark application no. UK00004428968 published in the journal no. 2026/034 (Aug. 21).
With Hogan Lovells Cadwalader International LLP as representative, Alcresta Therapeutics, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Medical nutritional formula, namely, formula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and wound healing, mental illness, pulmonary, muscular and respiratory diseases and disorders.
Class 10 : Filters for medical purposes, namely, for processing and converting medical nutritional formula.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004428968
Disclaimer: Curated by HT Syndication.
